Search Results
Aug 27, 2026, 09:00 ET Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis
failure.Importantly, the findings align with the substantial and growing international evidence base supporting HVHDF, including the landmark, EU-funded CONVINCE trial1, published in the New England Journal of Medicine and subsequent analyses demonstrating improved survival outcomes
More news about: Fresenius Medical Care Holdings, Inc.
Aug 27, 2026, 08:56 ET Rongtao Medical Publishes Legacy Ultrasound Cybersecurity Framework Built on FDA, CISA and OEM Evidence
[email protected] Note to EditorsFrank Zhu, General Manager, is available for interview through the company's contact page. The report covers the Olympus EU-ME2 end-of-support notice as its framing case, an analysis of the CISA Known Exploited Vulnerabilities catalog and ICS Medical Advisories series, a keyword
More news about: Rongtao Medical
Aug 27, 2026, 08:30 ET Advance Clinical Trial Enrichment with Operational Precision Biomarkers, Upcoming Webinar Hosted by Xtalks
Quanterix, for the live webinar on Tuesday, September 15, 2026, at 11am EDT (5pm CEST / EU-Central).For more information, or to register for this event, visit
More news about: Xtalks
Aug 27, 2026, 08:30 ET Assessing the Use of Non-Human Primates in Translational Research Today, Upcoming Webinar Hosted by Xtalks
Molecular PET, Department of Clinical Neuroscience, Karolinska Institutet, for the live webinar on Friday, September 25, 2026, at 11am EDT (5pm CEST / EU-Central).For more information, or to register for this event, visit
More news about: Xtalks
Aug 27, 2026, 07:43 ET Piramal Pharma renforce ses opérations prêtes pour l'avenir avec une réduction de 22,6 % des émissions, 41 % des énergies renouvelables et « zéro observation » de l'OAI par la FDA américaine
la communautéAu cours de l'exercice 2025-2026, Piramal Pharma a investi 8,98 crores dans des initiatives de RSE, a eu un impact positif sur près de 1,8 million de personnes dans 112 districts aux aspirations ambitieuses en s'appuyant sur des programmes de soins
More news about: Piramal Pharma Limited
Aug 27, 2026, 07:02 ET Fosun International Reports 1H2026 Results: Total Revenue RMB86.96 Billion, Net Profit RMB1.72 Billion
the revenue mix continues to improve. Henlius' HANSIZHUANG was approved for three new indications in the European Union (EU), while HLX11 (pertuzumab injection) was approved in the EU and two HLX14 (denosumab injection) products were approved and commercially launched in Canada. To date, Henlius has 10
More news about: Fosun
Aug 27, 2026, 07:00 ET PHOSGO Officially Launches World's First Mass-Produced Solar E-Bike Series on Indiegogo
Ultra up to 30 days of commuting without plugging in under favorable conditions.The Go5 Series will also be offered in regional configurations. EU versions use compliant 250 W pedal-assist systems with motor assistance limited to 25 km/h. Australian configurations will be supplied in accordance
More news about: PHOSGO
Aug 27, 2026, 06:51 ET Systemair AB Interim report Q1 2026/27, May - July
[email protected] Note: This information is information that Systemair is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out
More news about: Systemair AB
Aug 27, 2026, 03:33 ET Unlimit Mobile Unlocks Instant, Contract-Free UK eSIM Connectivity for Indian Students
provide flexible global roaming bundles and multi-country packages covering Europe and over 180+ global destinations, allowing seamless travel across the EU without having to switch carriers. The service also provides 24/7 customer support for users.About Unlimit MobileUnlimit Mobile
More news about: Unlimit Mobile
Aug 27, 2026, 03:00 ET Mitrade Sponsors World Snooker Tour, Backing the Action Across Europe's Snooker Heartlands
in European culture for generations — passionate crowds, historic venues, a fanbase that takes the game seriously," said Timur Konsky, CEO of Mitrade EU. "We're proud to support the World Snooker Tour as it enters its new season, and we look forward to being part of its community across Europe.""We
More news about: Mitrade Group
Aug 27, 2026, 03:00 ET Mitrade sponsert die World Snooker Tour und unterstützt das Geschehen in den europäischen Snooker-Hochburgen
mit leidenschaftlichen Zuschauern, historischen Spielstätten und einer Fangemeinde, die den Sport ernst nimmt", sagte Timur Konsky, CEO von Mitrade EU. „Wir sind stolz darauf, die World Snooker Tour zum Start ihrer neuen Saison zu unterstützen, und freuen uns darauf, Teil ihrer Community in ganz Europa
More news about: Mitrade Group
Aug 27, 2026, 02:30 ET Bittium launches new Faros Pro™ ECG device and EasyFlex™ single-use electrode patch for long-term ambulatory ECG monitoring
bringing increasingly cutting edge ECG technology to market in the future."Bittium Faros Pro is CE marked in accordance with the EU Medical Device Regulation (EU) 2017/745 (MDR). Product availability may vary by market. Bittium Faros Pro and Bittium EasyFlex will be presented at ESC Congress 2026
More news about: Bittium Oyj
Aug 27, 2026, 02:16 ET Biosidus mở rộng công suất sản xuất thuốc sinh học, củng cố năng lực cung ứng agalsidase beta trên toàn cầu
multimedia:https://www.prnewswire.com/vn/news-releases/u0062u0069u006Fu0073u0069u0064u0075u0073u002Du006Du1EDFu002Du0072u1ED9u006Eu0067u002Du0063u006Fu006Eu0067u002Du0073u0075u1EA5u0074u002Du0073-302861448.htmlSOURCE
More news about: Biosidus
Aug 27, 2026, 02:00 ET AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
approved for the treatment of Crohn's disease in the European Union (EU) to treat adults with moderately to severely active Crohn's disease who have had inadequate response, lost response or were intolerant to conventional
More news about: AbbVie
Aug 27, 2026, 02:00 ET TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
TEZSPIRE is currently approved for the treatment of severe asthma in the U.S., EU, China, Japan and more than 70 countries across the globe, and for the treatment of inadequately controlled CRSwNP in the U.S., EU, China and Japan.Beyond severe asthma and CRSwNP, TEZSPIRE is also in development
More news about: Amgen
Aug 27, 2026, 01:16 ET Boliden to acquire controlling stake in Nexa Resources
[email protected] This information is information that Boliden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of contact person above, at 07:00 CEST on August 27, 2026.Important
More news about: Boliden
Aug 27, 2026, 01:00 ET Saudi Arabia imports of canned tomatoes from the EU and Italy continue to grow in 2025 and 2026
The "Red Gold from Europe" Campaign will highlight the Quality, Security and Versatility of Italian and EU Canned Tomatoes at The Saudi Food Show 2026.NAPLES, Italy, Aug.
More news about: Red Gold from Europe
Aug 27, 2026, 00:39 ET 디 인터내셔널 2026, 상하이에서 성료... e스포츠와 문화 및 세계적 연결성 기념
multimedia:https://www.prnewswire.com/kr/news-releases/uB514u002DuC778uD130uB0B4uC154uB110u002Du0032u0030u0032u0036u002Cu002DuC0C1uD558uC774uC5D0uC11Cu002DuC131uB8CCu002Eu002Eu002Eu002Du0065uC2A4-302861299.htmlSOURCE
More news about: Perfect World
Aug 26, 2026, 23:44 ET A Terapower estreia na América do Sul na Intersolar 2026 com sistemas de armazenamento de energia em corrente alternada (CA), que contribuem para a formação da rede elétrica
incremental, maximizando a produção disponível. Para grandes usinas, a empresa apresenta o conversor de armazenamento de energia centralizado PC1565KTL-C/EU, de 1,56 MW, que oferece eficiência máxima superior a 99% e mantém a eficiência de conversão acima de 98,5% em plena carga.Ambas contam com
More news about: Terapower
Aug 26, 2026, 23:40 ET Terapower se estrena en Sudamérica en Intersolar 2026 con un sistema de almacenamiento acoplado en CA para la estabilización de la red
disponible. Para las grandes estaciones centralizadas, Terapower presenta su convertidor de almacenamiento de energía centralizado de 1,56 MW (PC1565KTL-C/EU), que ofrece una eficiencia máxima superior al 99 % y mantiene una eficiencia de conversión superior al 98,5 % a plena carga.Ambas plataformas
More news about: Terapower
Aug 26, 2026, 23:00 ET Exascend triển khai các giải pháp lưu trữ đạt chuẩn y tế tiên tiến, hỗ trợ các hệ thống chăm sóc sức khỏe thế hệ mới
content:https://www.prnewswire.com/vn/news-releases/u0065u0078u0061u0073u0063u0065u006Eu0064u002Du0074u0072u0069u1EC3u006Eu002Du006Bu0068u0061u0069u002Du0063u0061u0063u002Du0067u0069u1EA3u0069-302858482.htmlSOURCE
More news about: Exascend
Aug 26, 2026, 20:37 ET JustMarkets: Chấp Nhận Hay Né Tránh Rủi Ro? Đọc Vị Tâm Lý Thị Trường
multimedia:https://www.prnewswire.com/vn/news-releases/u006Au0075u0073u0074u006Du0061u0072u006Bu0065u0074u0073u003Au002Du0063u0068u1EA5u0070u002Du006Eu0068u1EADu006Eu002Du0068u0061u0079u002Du006E-302861071.htmlSOURCE
More news about: Just Global Markets Ltd
Aug 26, 2026, 12:52 ET PÁTIO HIGIENÓPOLIS APRESENTA CONCERTO GRATUITO COM MAESTRO JOÃO CARLOS MARTINS E ORQUESTRA BACHIANA FILARMÔNICA SESI-SP
Heitor Villa-LobosCon te Partirò - Francesco Sartori e Lucio QuarantottoMy Way - Jacques Revaux e Claude FrançoisEu sei que vou te Amar - Tom Jobim e Vinicius de MoraesLibertango - Astor PiazzollaIl Postino - Luis BacalovCine Paradiso
More news about: Shopping Pátio Higienópolis
Aug 26, 2026, 11:11 ET DOTT PUBLISHES Q2 2026 FINANCIAL REPORT AND PRELIMINARY JULY RESULTS, NARROWS FY 2026 GUIDANCE
[email protected] This information is information that Tier Mobility SE is obliged to make public pursuant to the EU Market Abuse Regulation.About DottDott is the European champion of shared micromobility. Created through the merger of
More news about: Dott
Aug 26, 2026, 10:41 ET Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
cancer therapy, market share of individual therapies, and current and forecasted market size from 2022 to 2036, segmented into leading markets (the US, EU4, UK, and Japan).
More news about: DelveInsight Business Research, LLP